Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study

被引：0
|
作者：
T. Susanna Meijer
Mark C. Burgmans
Eleonora M. de Leede
Lioe-Fee de Geus-Oei
Bas Boekestijn
Henricus J. M. Handgraaf
Denise E. Hilling
Jacob Lutjeboer
Jaap Vuijk
Christian H. Martini
Arian R. van Erkel
Rutger W. van der Meer
Fred G. J. Tijl
Frank M. Speetjens
Ellen Kapiteijn
Alexander L. Vahrmeijer
机构：
[1] Leiden University Medical Center,Department of Radiology
[2] Leiden University Medical Center,Department of Surgery
[3] University of Twente,Biomedical Photonic Imaging Group
[4] Leiden University Medical Center,Department of Anesthesiology
[5] Leiden University Medical Center,Department of Extra Corporal Circulation
[6] Leiden University Medical Center,Department of Medical Oncology
来源：
Annals of Surgical Oncology | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1130 / 1141
页数：11
相关论文
共 50 条
  • [1] Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Ocular Melanoma Metastases Confined to the Liver: A Prospective Phase II Study
    Meijer, T. Susanna
    Burgmans, Mark C.
    de Leede, Eleonora M.
    de Geus-Oei, Lioe-Fee
    Boekestijn, Bas
    Handgraaf, Henricus J. M.
    Hilling, Denise E.
    Lutjeboer, Jacob
    Vuijk, Jaap
    Martini, Christian H.
    van Erkel, Arian R.
    van der Meer, Rutger W.
    Tijl, Fred G. J.
    Speetjens, Frank M.
    Kapiteijn, Ellen
    Vahrmeijer, Alexander L.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (02) : 1130 - 1141
  • [2] Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
    de Leede, Eleonora M.
    Burgmans, Mark C.
    Martini, Christian H.
    Tijl, Fred G. J.
    van Erkel, Arian R.
    Vuyk, Jaap
    Kapiteijn, Ellen
    Verhoef, Cornelis
    van de Velde, Cornelis J. H.
    Vahrmeijer, Alexander L.
    [J]. JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2016, (113):
  • [3] ASO Author Reflections: Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Hepatic Metastases from Ocular Melanoma
    T. Susanna Meijer
    Mark C. Burgmans
    [J]. Annals of Surgical Oncology, 2020, 27 : 820 - 821
  • [4] ASO Author Reflections: Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Hepatic Metastases from Ocular Melanoma
    Meijer, T. Susanna
    Burgmans, Mark C.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (Suppl 3) : 820 - 821
  • [5] Embolization of variant hepatic arteries in patients undergoing percutaneous hepatic perfusion for unresectable liver metastases from ocular melanoma
    Meijer, T. Susanna
    De Geus-Oei, Lioe-Fee
    Martini, Christian H.
    Tijl, Fred G. J.
    Sitsen, M. Elske
    van Erkel, Arian R.
    van Der Meer, Rutger W.
    Kapiteijn, Ellen
    Vahrmeijer, Alexander L.
    Burgmans, Mark C.
    [J]. DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY, 2019, 25 (06) : 451 - 458
  • [6] Prospective evaluation of percutaneous hepatic perfusion with melphalan as a treatment for unresectable liver metastases from colorectal cancer
    Meijer, T. Susanna
    Dieters, Jan H. N.
    de Leede, Eleonora M.
    de Geus-Oei, Lioe-Fee
    Vuijk, Jaap
    Martini, Christian H.
    van Erkel, Arian R.
    Lutjeboer, Jacob
    van der Meer, Rutger W.
    Tijl, Fred G. J.
    Kapiteijn, Ellen
    Vahrmeijer, Alexander L.
    Burgmans, Mark C.
    [J]. PLOS ONE, 2022, 17 (01):
  • [7] Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems’ Second-Generation Hemofiltration System: A Prospective Non-randomized Phase II Trial
    T. Susanna Meijer
    Mark C. Burgmans
    Marta Fiocco
    Lioe-Fee de Geus-Oei
    Ellen Kapiteijn
    Eleonora M. de Leede
    Christian H. Martini
    Rutger W. van der Meer
    Fred G. J. Tijl
    Alexander L. Vahrmeijer
    [J]. CardioVascular and Interventional Radiology, 2019, 42 : 841 - 852
  • [8] Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems' Second-Generation Hemofiltration System: A Prospective Non-randomized Phase II Trial
    Meijer, T. Susanna
    Burgmans, Mark C.
    Fiocco, Marta
    de Geus-Oei, Lioe-Fee
    Kapiteijn, Ellen
    de Leede, Eleonora M.
    Martini, Christian H.
    van der Meer, Rutger W.
    Tijl, Fred G. J.
    Vahrmeijer, Alexander L.
    [J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2019, 42 (06) : 841 - 852
  • [9] Ocular melanoma liver metastases treated by percutaneous hepatic perfusion with melphalan followed by ipilimumab: A case report.
    Idris, Ahmad Fitri
    Martin, Michael John
    Davidson, Ian R.
    O'Sullivan, Gerard J.
    Jamaludin, Ahmad A.
    Donnellan, Paul P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] Predictive Parameters in Patients Undergoing Percutaneous Hepatic Perfusion with Melphalan for Unresectable Liver Metastases from Uveal Melanoma: A Retrospective Pooled Analysis
    T. M. L. Tong
    M. Samim
    E. Kapiteijn
    T. S. Meijer
    F. M. Speetjens
    R. Brüning
    T. H. Schroeder
    S. El-Sanosy
    H. Maschke
    F. K. Wacker
    A. Vogel
    C. L. A. Dewald
    J. J. Goeman
    M. C. Burgmans
    [J]. CardioVascular and Interventional Radiology, 2022, 45 : 1304 - 1313
12345